MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

Jeffrey B. Kopp, Michael W. Smith, George W. Nelson, Randall C. Johnson, Barry I. Freedman, Donald W. Bowden, Taras Oleksyk, Louise M. McKenzie, Hiroshi Kajiyama, Tejinder S. Ahuja, Jeffrey S. Berns, William Briggs, Monique E. Cho, Richard A. Dart, Paul L. Kimmel, Stephen M. Korbet, Donna M. Michel, Michele H. Mokrzycki, Jeffrey R. Schelling, Eric Simon & 3 others Howard Trachtman, David Vlahov, Cheryl A. Winkler

Research output: Contribution to journalArticle

Abstract

The increased burden of chronic kidney and end-stage kidney diseases (ESKD) in populations of African ancestry has been largely unexplained. To identify genetic variants predisposing to idiopathic and HIV-1-associated focal segmental glomerulosclerosis (FSGS), we carried out an admixture-mapping linkage-disequilibrium genome scan on 190 African American individuals with FSGS and 222 controls. We identified a chromosome 22 region with a genome-wide logarithm of the odds (lod) score of 9.2 and a peak lod of 12.4 centered on MYH9, a functional candidate gene expressed in kidney podocytes. Multiple MYH9 SNPs and haplotypes were recessively associated with FSGS, most strongly a haplotype spanning exons 14 through 23 (OR = 5.0, 95% CI = 3.5-7.1; P = 4 × 10-23, n = 852). This association extended to hypertensive ESKD (OR = 2.2, 95% CI = 1.5-3.4; n = 433), but not type 2 diabetic ESKD (n = 476). Genetic variation at the MYH9 locus substantially explains the increased burden of FSGS and hypertensive ESKD among African Americans.

Original languageEnglish (US)
Pages (from-to)1175-1184
Number of pages10
JournalNature Genetics
Volume40
Issue number10
DOIs
StatePublished - Oct 2008
Externally publishedYes

Fingerprint

Focal Segmental Glomerulosclerosis
Chronic Kidney Failure
African Americans
Haplotypes
Genes
Genome
Kidney
Chromosomes, Human, Pair 22
Podocytes
Linkage Disequilibrium
Diabetic Nephropathies
Single Nucleotide Polymorphism
HIV-1
Exons
Population

ASJC Scopus subject areas

  • Genetics

Cite this

Kopp, J. B., Smith, M. W., Nelson, G. W., Johnson, R. C., Freedman, B. I., Bowden, D. W., ... Winkler, C. A. (2008). MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nature Genetics, 40(10), 1175-1184. https://doi.org/10.1038/ng.226

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. / Kopp, Jeffrey B.; Smith, Michael W.; Nelson, George W.; Johnson, Randall C.; Freedman, Barry I.; Bowden, Donald W.; Oleksyk, Taras; McKenzie, Louise M.; Kajiyama, Hiroshi; Ahuja, Tejinder S.; Berns, Jeffrey S.; Briggs, William; Cho, Monique E.; Dart, Richard A.; Kimmel, Paul L.; Korbet, Stephen M.; Michel, Donna M.; Mokrzycki, Michele H.; Schelling, Jeffrey R.; Simon, Eric; Trachtman, Howard; Vlahov, David; Winkler, Cheryl A.

In: Nature Genetics, Vol. 40, No. 10, 10.2008, p. 1175-1184.

Research output: Contribution to journalArticle

Kopp, JB, Smith, MW, Nelson, GW, Johnson, RC, Freedman, BI, Bowden, DW, Oleksyk, T, McKenzie, LM, Kajiyama, H, Ahuja, TS, Berns, JS, Briggs, W, Cho, ME, Dart, RA, Kimmel, PL, Korbet, SM, Michel, DM, Mokrzycki, MH, Schelling, JR, Simon, E, Trachtman, H, Vlahov, D & Winkler, CA 2008, 'MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis', Nature Genetics, vol. 40, no. 10, pp. 1175-1184. https://doi.org/10.1038/ng.226
Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nature Genetics. 2008 Oct;40(10):1175-1184. https://doi.org/10.1038/ng.226
Kopp, Jeffrey B. ; Smith, Michael W. ; Nelson, George W. ; Johnson, Randall C. ; Freedman, Barry I. ; Bowden, Donald W. ; Oleksyk, Taras ; McKenzie, Louise M. ; Kajiyama, Hiroshi ; Ahuja, Tejinder S. ; Berns, Jeffrey S. ; Briggs, William ; Cho, Monique E. ; Dart, Richard A. ; Kimmel, Paul L. ; Korbet, Stephen M. ; Michel, Donna M. ; Mokrzycki, Michele H. ; Schelling, Jeffrey R. ; Simon, Eric ; Trachtman, Howard ; Vlahov, David ; Winkler, Cheryl A. / MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. In: Nature Genetics. 2008 ; Vol. 40, No. 10. pp. 1175-1184.
@article{86322203bee84c5f96ee96b2008027a9,
title = "MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis",
abstract = "The increased burden of chronic kidney and end-stage kidney diseases (ESKD) in populations of African ancestry has been largely unexplained. To identify genetic variants predisposing to idiopathic and HIV-1-associated focal segmental glomerulosclerosis (FSGS), we carried out an admixture-mapping linkage-disequilibrium genome scan on 190 African American individuals with FSGS and 222 controls. We identified a chromosome 22 region with a genome-wide logarithm of the odds (lod) score of 9.2 and a peak lod of 12.4 centered on MYH9, a functional candidate gene expressed in kidney podocytes. Multiple MYH9 SNPs and haplotypes were recessively associated with FSGS, most strongly a haplotype spanning exons 14 through 23 (OR = 5.0, 95{\%} CI = 3.5-7.1; P = 4 × 10-23, n = 852). This association extended to hypertensive ESKD (OR = 2.2, 95{\%} CI = 1.5-3.4; n = 433), but not type 2 diabetic ESKD (n = 476). Genetic variation at the MYH9 locus substantially explains the increased burden of FSGS and hypertensive ESKD among African Americans.",
author = "Kopp, {Jeffrey B.} and Smith, {Michael W.} and Nelson, {George W.} and Johnson, {Randall C.} and Freedman, {Barry I.} and Bowden, {Donald W.} and Taras Oleksyk and McKenzie, {Louise M.} and Hiroshi Kajiyama and Ahuja, {Tejinder S.} and Berns, {Jeffrey S.} and William Briggs and Cho, {Monique E.} and Dart, {Richard A.} and Kimmel, {Paul L.} and Korbet, {Stephen M.} and Michel, {Donna M.} and Mokrzycki, {Michele H.} and Schelling, {Jeffrey R.} and Eric Simon and Howard Trachtman and David Vlahov and Winkler, {Cheryl A.}",
year = "2008",
month = "10",
doi = "10.1038/ng.226",
language = "English (US)",
volume = "40",
pages = "1175--1184",
journal = "Nature Genetics",
issn = "1061-4036",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

AU - Kopp, Jeffrey B.

AU - Smith, Michael W.

AU - Nelson, George W.

AU - Johnson, Randall C.

AU - Freedman, Barry I.

AU - Bowden, Donald W.

AU - Oleksyk, Taras

AU - McKenzie, Louise M.

AU - Kajiyama, Hiroshi

AU - Ahuja, Tejinder S.

AU - Berns, Jeffrey S.

AU - Briggs, William

AU - Cho, Monique E.

AU - Dart, Richard A.

AU - Kimmel, Paul L.

AU - Korbet, Stephen M.

AU - Michel, Donna M.

AU - Mokrzycki, Michele H.

AU - Schelling, Jeffrey R.

AU - Simon, Eric

AU - Trachtman, Howard

AU - Vlahov, David

AU - Winkler, Cheryl A.

PY - 2008/10

Y1 - 2008/10

N2 - The increased burden of chronic kidney and end-stage kidney diseases (ESKD) in populations of African ancestry has been largely unexplained. To identify genetic variants predisposing to idiopathic and HIV-1-associated focal segmental glomerulosclerosis (FSGS), we carried out an admixture-mapping linkage-disequilibrium genome scan on 190 African American individuals with FSGS and 222 controls. We identified a chromosome 22 region with a genome-wide logarithm of the odds (lod) score of 9.2 and a peak lod of 12.4 centered on MYH9, a functional candidate gene expressed in kidney podocytes. Multiple MYH9 SNPs and haplotypes were recessively associated with FSGS, most strongly a haplotype spanning exons 14 through 23 (OR = 5.0, 95% CI = 3.5-7.1; P = 4 × 10-23, n = 852). This association extended to hypertensive ESKD (OR = 2.2, 95% CI = 1.5-3.4; n = 433), but not type 2 diabetic ESKD (n = 476). Genetic variation at the MYH9 locus substantially explains the increased burden of FSGS and hypertensive ESKD among African Americans.

AB - The increased burden of chronic kidney and end-stage kidney diseases (ESKD) in populations of African ancestry has been largely unexplained. To identify genetic variants predisposing to idiopathic and HIV-1-associated focal segmental glomerulosclerosis (FSGS), we carried out an admixture-mapping linkage-disequilibrium genome scan on 190 African American individuals with FSGS and 222 controls. We identified a chromosome 22 region with a genome-wide logarithm of the odds (lod) score of 9.2 and a peak lod of 12.4 centered on MYH9, a functional candidate gene expressed in kidney podocytes. Multiple MYH9 SNPs and haplotypes were recessively associated with FSGS, most strongly a haplotype spanning exons 14 through 23 (OR = 5.0, 95% CI = 3.5-7.1; P = 4 × 10-23, n = 852). This association extended to hypertensive ESKD (OR = 2.2, 95% CI = 1.5-3.4; n = 433), but not type 2 diabetic ESKD (n = 476). Genetic variation at the MYH9 locus substantially explains the increased burden of FSGS and hypertensive ESKD among African Americans.

UR - http://www.scopus.com/inward/record.url?scp=52949110955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52949110955&partnerID=8YFLogxK

U2 - 10.1038/ng.226

DO - 10.1038/ng.226

M3 - Article

VL - 40

SP - 1175

EP - 1184

JO - Nature Genetics

JF - Nature Genetics

SN - 1061-4036

IS - 10

ER -